Link to this page
Medical Subject Headings
Last uploaded:
August 28, 2024
Jump to:
Preferred Name | temsirolimus | |
Synonyms |
rapamycin 42-(2,2-bis(hydroxymethyl)propionate) CCI 779 rapamycin, 42-(3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate) Torisel CCI-779 |
|
ID |
http://purl.bioontology.org/ontology/MESH/C401859 |
|
altLabel |
rapamycin 42-(2,2-bis(hydroxymethyl)propionate) CCI 779 rapamycin, 42-(3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate) Torisel CCI-779
|
|
cui |
C0796512 C1951646 C1707080
|
|
Has mapping qualifier | ||
HM |
D020123/Q000031
|
|
II |
D047428 D000970
|
|
Inverse of RB |
624KN6GM2T 0
|
|
isa | ||
LT |
TRD
|
|
Mapped to | ||
MDA |
19991217
|
|
MeSH Frequency |
884
|
|
MMR |
20210701
|
|
notation |
C401859
|
|
PA |
D000091203
|
|
prefLabel |
temsirolimus
|
|
SC |
1
|
|
Scope Statement |
structure in first source; inhibits mTOR protein
|
|
SRC |
Bull Cancer 1999 Oct;86(10):808-11
|
|
TERMUI |
T000913136 T707936 T403101 T403100 T675184
|
|
TH |
NLM (1999) FDA SRS (2017) USAN (19XX) INN (19XX) NLM (2006) FDA SRS (2015) NLM (2017) NLM (2007)
|
|
tui |
T109 T121
|
Add comment
Delete | Subject | Author | Type | Created |
---|---|---|---|---|
No notes to display |
Create mapping